|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hellerstedt BA and Pienta KJ: The current
state of hormonal therapy for prostate cancer. CA Cancer J Clin.
52:154–179. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bubendorf L, Schöpfer A, Wagner U, Sauter
G, Moch H, Willi N, Gasser TC and Mihatsch MJ: Metastatic patterns
of prostate cancer: An autopsy study of 1,589 patients. Hum Pathol.
31:578–583. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Heidenreich A, Aus G, Bolla M, Joniau S,
Matveev VB, Schmid HP and Zattoni F; European Association of
Urology. EAU guidelines on prostate cancer. Eur Urol. 53:68–80.
2008. View Article : Google Scholar
|
|
5
|
Antonarakis ES and Eisenberger MA:
Expanding treatment options for metastatic prostate cancer. N Engl
J Med. 364:2055–2058. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shah RB, Mehra R, Chinnaiyan AM, Shen R,
Ghosh D, Zhou M, Macvicar GR, Varambally S, Harwood J, Bismar TA,
et al: Androgen-independent prostate cancer is a heterogeneous
group of diseases: Lessons from a rapid autopsy program. Cancer
Res. 64:9209–9216. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Petrylak DP, Tangen CM, Hussain MH, Lara
PN Jr, Jones JA, Taplin ME, Burch PA, Berry D, Moinpour C, Kohli M,
et al: Docetaxel and estramustine compared with mitoxantrone and
prednisone for advanced refractory prostate cancer. N Engl J Med.
351:1513–1520. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tannock IF, de Wit R, Berry WR, Horti J,
Pluzanska A, Chi KN, Oudard S, Théodore C, James ND, Turesson I, et
al; TAX 327 Investigators. Docetaxel plus prednisone or
mitoxantrone plus prednisone for advanced prostate cancer. N Engl J
Med. 351:1502–1512. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wall ME, Ward EC, Cook CE, Palmer KH,
McPhail HT and Sim GA: Plant antitumor agents. I. The isolation and
structure of camptothecin, a novel alkaloidal leukemia and tumor
inhibitor from Camptotheca acuminata. J Am Chem Soc. 88:3888–3890.
1966. View Article : Google Scholar
|
|
10
|
Wall ME: Camptothecin and taxol: Discovery
to clinic. Med Res Rev. 18:299–314. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pizzolato JF and Saltz LB: The
camptothecins. Lancet. 361:2235–2242. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pommier Y: Topoisomerase I inhibitors:
Camptothecins and beyond. Nat Rev Cancer. 6:789–802. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rapisarda A, Uranchimeg B, Scudiero DA,
Selby M, Sausville EA, Shoemaker RH and Melillo G: Identification
of small molecule inhibitors of hypoxia-inducible factor 1
transcriptional activation pathway. Cancer Res. 62:4316–4324.
2002.PubMed/NCBI
|
|
14
|
Song MG, Gao SM, Du KM, Xu M, Yu Y, Zhou
YH, Wang Q, Chen Z, Zhu YS and Chen GQ: Nanomolar concentration of
NSC606985, a camptothecin analog, induces leukemic-cell apoptosis
through protein kinase Cdelta-dependent mechanisms. Blood.
105:3714–3721. 2005. View Article : Google Scholar
|
|
15
|
Tan C, Cai LQ, Wu W, Qiao Y,
Imperato-McGinley J, Chen GQ and Zhu YS: NSC606985, a novel
camptothecin analog, induces apoptosis and growth arrest in
prostate tumor cells. Cancer Chemother Pharmacol. 63:303–312. 2009.
View Article : Google Scholar
|
|
16
|
Harding HP, Calfon M, Urano F, Novoa I and
Ron D: Transcriptional and translational control in the Mammalian
unfolded protein response. Annu Rev Cell Dev Biol. 18:575–599.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rutkowski DT and Kaufman RJ: A trip to the
ER: Coping with stress. Trends Cell Biol. 14:20–28. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Binet F and Sapieha P: ER stress and
angiogenesis. Cell Metab. 22:560–575. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schröder M and Kaufman RJ: The mammalian
unfolded protein response. Annu Rev Biochem. 74:739–789. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim I, Xu W and Reed JC: Cell death and
endoplasmic reticulum stress: Disease relevance and therapeutic
opportunities. Nat Rev Drug Discov. 7:1013–1030. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Marciniak SJ and Ron D: Endoplasmic
reticulum stress signaling in disease. Physiol Rev. 86:1133–1149.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Szegezdi E, Logue SE, Gorman AM and Samali
A: Mediators of endoplasmic reticulum stress-induced apoptosis.
EMBO Rep. 7:880–885. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu YS, Cai LQ, You X, Cordero JJ, Huang Y
and Imperato-McGinley J: Androgen-induced prostate-specific antigen
gene expression is mediated via dihydrotestosterone in LNCaP cells.
J Androl. 24:681–687. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cai J, Hong Y, Weng C, Tan C,
Imperato-McGinley J and Zhu YS: Androgen stimulates endothelial
cell proliferation via an androgen receptor/VEGF/cyclin A-mediated
mechanism. Am J Physiol Heart Circ Physiol. 300:H1210–H1221. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wen J, Zhao Y, Li J, Weng C, Cai J, Yang
K, Yuan H, Imperato-McGinley J and Zhu YS: Suppression of
DHT-induced paracrine stimulation of endothelial cell growth by
estrogens via prostate cancer cells. Prostate. 73:1069–1081. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Baydas G, Reiter RJ, Akbulut M, Tuzcu M
and Tamer S: Melatonin inhibits neural apoptosis induced by
homocysteine in hippocampus of rats via inhibition of cytochrome c
translocation and caspase-3 activation and by regulating pro- and
anti-apoptotic protein levels. Neuroscience. 135:879–886. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kisselev AF and Goldberg AL: Proteasome
inhibitors: From research tools to drug candidates. Chem Biol.
8:739–758. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Villalpando Rodriguez GE and Torriglia A:
Calpain 1 induce lysosomal permeabilization by cleavage of
lysosomal associated membrane protein 2. Biochim Biophys Acta.
1833:2244–2253. 2013. View Article : Google Scholar
|
|
29
|
Ozcan U, Yilmaz E, Ozcan L, Furuhashi M,
Vaillancourt E, Smith RO, Görgün CZ and Hotamisligil GS: Chemical
chaperones reduce ER stress and restore glucose homeostasis in a
mouse model of type 2 diabetes. Science. 313:1137–1140. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Benz C, Angermüller S, Töx U,
Klöters-Plachky P, Riedel HD, Sauer P, Stremmel W and Stiehl A:
Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis
and cytolysis in rat hepatocytes. J Hepatol. 28:99–106. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kubota K, Niinuma Y, Kaneko M, Okuma Y,
Sugai M, Omura T, Uesugi M, Uehara T, Hosoi T and Nomura Y:
Suppressive effects of 4-phenylbutyrate on the aggregation of Pael
receptors and endoplasmic reticulum stress. J Neurochem.
97:1259–1268. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Luo ZF, Feng B, Mu J, Qi W, Zeng W, Guo
YH, Pang Q, Ye ZL, Liu L and Yuan FH: Effects of 4-phenylbutyric
acid on the process and development of diabetic nephropathy induced
in rats by streptozotocin: Regulation of endoplasmic reticulum
stress-oxidative activation. Toxicol Appl Pharmacol. 246:49–57.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wiley JC, Meabon JS, Frankowski H, Smith
EA, Schecterson LC, Bothwell M and Ladiges WC: Phenylbutyric acid
rescues endoplasmic reticulum stress-induced suppression of APP
proteolysis and prevents apoptosis in neuronal cells. PLoS One.
5:e91352010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zinszner H, Kuroda M, Wang X, Batchvarova
N, Lightfoot RT, Remotti H, Stevens JL and Ron D: CHOP is
implicated in programmed cell death in response to impaired
function of the endoplasmic reticulum. Genes Dev. 12:982–995. 1998.
View Article : Google Scholar
|
|
35
|
Marciniak SJ, Yun CY, Oyadomari S, Novoa
I, Zhang Y, Jungreis R, Nagata K, Harding HP and Ron D: CHOP
induces death by promoting protein synthesis and oxidation in the
stressed endoplasmic reticulum. Genes Dev. 18:3066–3077. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Watanabe Y, Tsuchiya H, Sakabe T, Matsuoka
S, Akechi Y, Fujimoto Y, Yamane K, Ikeda R, Nishio R, Terabayashi
K, et al: CD437 induces apoptosis in ovarian adenocarcinoma cells
via ER stress signaling. Biochem Biophys Res Commun. 366:840–847.
2008. View Article : Google Scholar
|
|
37
|
Zhang K and Kaufman RJ: From
endoplasmic-reticulum stress to the inflammatory response. Nature.
454:455–462. 2008. View Article : Google Scholar
|
|
38
|
Logue SE, Cleary P, Saveljeva S and Samali
A: New directions in ER stress-induced cell death. Apoptosis.
18:537–546. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bertolotti A, Zhang Y, Hendershot LM,
Harding HP and Ron D: Dynamic interaction of BiP and ER stress
transducers in the unfolded-protein response. Nat Cell Biol.
2:326–332. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi
NN, Ozdelen E, Tuncman G, Görgün C, Glimcher LH and Hotamisligil
GS: Endoplasmic reticulum stress links obesity, insulin action, and
type 2 diabetes. Science. 306:457–461. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ozcan L, Ergin AS, Lu A, Chung J, Sarkar
S, Nie D, Myers MG Jr and Ozcan U: Endoplasmic reticulum stress
plays a central role in development of leptin resistance. Cell
Metab. 9:35–51. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Deldicque L, Cani PD, Philp A, Raymackers
JM, Meakin PJ, Ashford ML, Delzenne NM, Francaux M and Baar K: The
unfolded protein response is activated in skeletal muscle by
high-fat feeding: Potential role in the downregulation of protein
synthesis. Am J Physiol Endocrinol Metab. 299:E695–E705. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Nivala AM, Reese L, Frye M, Gentile CL and
Pagliassotti MJ: Fatty acid-mediated endoplasmic reticulum stress
in vivo: Differential response to the infusion of Soybean and Lard
Oil in rats. Metabolism. 62:753–760. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nakamura S, Takizawa H, Shimazawa M,
Hashimoto Y, Sugitani S, Tsuruma K and Hara H: Mild endoplasmic
reticulum stress promotes retinal neovascularization via induction
of BiP/ GRP78. PLoS One. 8:e605172013. View Article : Google Scholar
|
|
45
|
Pierre N, Deldicque L, Barbé C, Naslain D,
Cani PD and Francaux M: Toll-like receptor 4 knockout mice are
protected against endoplasmic reticulum stress induced by a
high-fat diet. PLoS One. 8:e650612013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lee AS: GRP78 induction in cancer:
Therapeutic and prognostic implications. Cancer Res. 67:3496–3499.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
D'Hertog W, Maris M, Ferreira GB,
Verdrengh E, Lage K, Hansen DA, Cardozo AK, Workman CT, Moreau Y,
Eizirik DL, et al: Novel insights into the global proteome
responses of insulin-producing INS-1E cells to different degrees of
endoplasmic reticulum stress. J Proteome Res. 9:5142–5152. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Rosengren V, Johansson H, Lehtiö J,
Fransson L, Sjöholm A and Ortsäter H: Thapsigargin down-regulates
protein levels of GRP78/BiP in INS-1E cells. J Cell Biochem.
113:1635–1644. 2012.
|
|
49
|
Scheuner D and Kaufman RJ: The unfolded
protein response: A pathway that links insulin demand with
beta-cell failure and diabetes. Endocr Rev. 29:317–333. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Meng L, Mohan R, Kwok BH, Elofsson M, Sin
N and Crews CM: Epoxomicin, a potent and selective proteasome
inhibitor, exhibits in vivo antiinflammatory activity. Proc Natl
Acad Sci USA. 96:10403–10408. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Bird PI, Trapani JA and Villadangos JA:
Endolysosomal proteases and their inhibitors in immunity. Nat Rev
Immunol. 9:871–882. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Turk V, Stoka V, Vasiljeva O, Renko M, Sun
T, Turk B and Turk D: Cysteine cathepsins: From structure, function
and regulation to new frontiers. Biochim Biophys Acta. 1824:68–88.
2012. View Article : Google Scholar
|
|
53
|
McCullough KD, Martindale JL, Klotz LO, Aw
TY and Holbrook NJ: Gadd153 sensitizes cells to endoplasmic
reticulum stress by down-regulating Bcl2 and perturbing the
cellular redox state. Mol Cell Biol. 21:1249–1259. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Tabas I and Ron D: Integrating the
mechanisms of apoptosis induced by endoplasmic reticulum stress.
Nat Cell Biol. 13:184–190. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Lu M, Lawrence DA, Marsters S,
Acosta-Alvear D, Kimmig P, Mendez AS, Paton AW, Paton JC, Walter P
and Ashkenazi A: Opposing unfolded-protein-response signals
converge on death receptor 5 to control apoptosis. Science.
345:98–101. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Shiraishi T, Yoshida T, Nakata S, Horinaka
M, Wakada M, Mizutani Y, Miki T and Sakai T: Tunicamycin enhances
tumor necrosis factor-related apoptosis-inducing ligand-induced
apoptosis in human prostate cancer cells. Cancer Res. 65:6364–6370.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Engin F and Hotamisligil GS: Restoring
endoplasmic reticulum function by chemical chaperones: An emerging
therapeutic approach for metabolic diseases. Diabetes Obes Metab.
12(Suppl 2): 108–115. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Ben Mosbah I, Alfany-Fernández I, Martel
C, Zaouali MA, Bintanel-Morcillo M, Rimola A, Rodés J, Brenner C,
Roselló-Catafau J and Peralta C: Endoplasmic reticulum stress
inhibition protects steatotic and non-steatotic livers in partial
hepatectomy under ischemia-reperfusion. Cell Death Dis. 1:e522010.
View Article : Google Scholar
|
|
59
|
Arrojo E, Drigo R, Fonseca TL, Castillo M,
Salathe M, Simovic G, Mohácsik P, Gereben B and Bianco AC:
Endoplasmic reticulum stress decreases intracellular thyroid
hormone activation via an eIF2a-mediated decrease in type 2
deiodinase synthesis. Mol Endocrinol. 25:2065–2075. 2011.
View Article : Google Scholar
|
|
60
|
Duricka DL, Brown RL and Varnum MD:
Defective trafficking of cone photoreceptor CNG channels induces
the unfolded protein response and ER-stress-associated cell death.
Biochem J. 441:685–696. 2012. View Article : Google Scholar :
|
|
61
|
Koyama M, Furuhashi M, Ishimura S, Mita T,
Fuseya T, Okazaki Y, Yoshida H, Tsuchihashi K and Miura T:
Reduction of endoplasmic reticulum stress by 4-phenylbutyric acid
prevents the development of hypoxia-induced pulmonary arterial
hypertension. Am J Physiol Heart Circ Physiol. 306:H1314–H1323.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Reddy RK, Mao C, Baumeister P, Austin RC,
Kaufman RJ and Lee AS: Endoplasmic reticulum chaperone protein
GRP78 protects cells from apoptosis induced by topoisomerase
inhibitors: Role of ATP binding site in suppression of caspase-7
activation. J Biol Chem. 278:20915–20924. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Fu HY, Minamino T, Tsukamoto O, Sawada T,
Asai M, Kato H, Asano Y, Fujita M, Takashima S, Hori M, et al:
Overexpression of endoplasmic reticulum-resident chaperone
attenuates cardiomyocyte death induced by proteasome inhibition.
Cardiovasc Res. 79:600–610. 2008. View Article : Google Scholar : PubMed/NCBI
|
